Covid-19 -- An Update -- October 17, 2022

Wuhan flu. The blog.  Coronavirus: statistics.     Seasonal flu: CDC.

A reminder: I continue to track / follow Covid-19 but a little bit differently. See this note.

When Covid-19 "first broke," I tried to follow the science, but it was not possible, and I made the mistake of getting too involved with the politics, emotions, personalities, conspiracy theories.

Now that books are starting to appear on the subject, I am now following Covid-19 for two reasons, or from two different aspects.

First, I'm back to following the science, and it's absolutely incredibly interesting.

Second, I'm looking at Covid-19 from an investor's point of view. 

Three books:

• The Code Breaker, Spike, and Breathless.
• My on-going notes on Breathless here.
• My on-going notes on Spike here.
• On-going notes on The Code Breaker yet to appear. I've just gotten the book. 

Where we stand on Covid-19, not ready for prime time; rambling, disjointed thoughts:

• research on the coronaviruses is going to open a whole new field in medicine;
• we're going to start seeing a lot more vaccine research, and a lot more anti-viral therapy research;
• coronaviruses are really, really bad viruses, not because of the diseases they actually cause (bad colds and pneumonia), but how they could impact the severity of other viruses, or lead to new pandemics
• but, I think medical research is now "ahead" of what coronaviruses can do and we will learn to live with them just as we've learned to live with other viruses
• engineered, laboratory gain-of-function? Absolutely not; a natural source
• medical researchers understand the science, always have; gradually that will trickle down to eighth-grade biology
• flu season, 2022 - 2023, will be of interest, but the flu season of 2023 - 2024 will be much more interesting
• Chinese handling of Covid-19 pandemic after August, 2022? Can't comment. I have never been to China, I certainly don't understand their challenges.